Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
申请人:Janssen Pharmaceuticals, Inc.
公开号:US20170298017A1
公开(公告)日:2017-10-19
The present invention concerns mono- or di-substituted indole derivatives (I) which are useful to prevent or treat dengue viral infections and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.